Search

Author/Creator Gillman, A.

1. 2579 Evaluation of clinical decision-making and the use of circulating tumor cells (CTCs) by physicians treating castration-resistant prostate cancer (CRPC). (September 2015)

Authors:
Lorente, D.; Ravi, P.; Mehra, N.; Gillman, A.; Omlin, A.; Pezaro, C.; Miranda, M.; Mateo, J.; Rescigno, P.; Kolinsky, M.; Porta, N.; Jayaram, A.; Bianchini, D.; Hall, E.; Ijzerman, M.J.; De Bono, J.S.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S504
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry. Issue 9 (16th September 2016)

Authors:
Gibson, P. G.; Reddel, H.; McDonald, V. M.; Marks, G.; Jenkins, C.; Gillman, A.; Upham, J.; Sutherland, M.; Rimmer, J.; Thien, F.; Katsoulotos, G. P.; Cook, M.; Yang, I.; Katelaris, C.; Bowler, S.; Langton, D.; Robinson, P.; Wright, C.; Yozghatlian, V.; Burgess, S.
Journal:
Internal medicine journal
Issue:
Volume 46:Issue 9(2016)
Page Start:
1054
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Real‐life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria. Issue 11 (22nd July 2016)

Authors:
Hew, M.; Gillman, A.; Sutherland, M.; Wark, P.; Bowden, J.; Guo, M.; Reddel, H. K.; Jenkins, C.; Marks, G. B.; Thien, F.; Rimmer, J.; Katsoulotos, G. P.; Cook, M.; Yang, I.; Katelaris, C.; Bowler, S.; Langton, D.; Wright, C.; Bint, M.; Yozghatlian, V.
Journal:
Clinical & experimental allergy
Issue:
Volume 46:Issue 11(2016:Nov.)
Page Start:
1407
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗